Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 88285967 | FILING DATE | 02/01/2019 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | ANDERSON, CASSONDRA CR |
L.O. ASSIGNED | 103 |
PUB INFORMATION |
|||
RUN DATE | 02/06/2020 | ||
PUB DATE | N/A | ||
STATUS | 680-APPROVED FOR PUBLICATION | ||
STATUS DATE | 02/05/2020 | ||
LITERAL MARK ELEMENT | AVANCE | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
44D | NO | 44D | NO | 44D | NO |
44E | NO | 44E | NO | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | YES |
LITERAL MARK ELEMENT | AVANCE |
MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | Axogen Corporation |
ADDRESS | 13631 Progress Blvd., Suite 400 Alachua, FL 32615 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | Implants comprising living tissue; Surgical implants comprised of biological tissue, namely, human and animal tissue, for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; medical and veterinary instruments and devices, namely, nerve and tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration |
INTERNATIONAL CLASS | 010 |
DESCRIPTION TEXT | Nervous tissue products, namely, medical, veterinary and surgical implant kits comprised of biological tissues for use in regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration; surgical implants comprised of synthetic materials; medical and veterinary devices, namely, nerve and tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 010 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
02/05/2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 021 |
02/05/2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 020 |
02/05/2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 019 |
02/04/2020 | ALIE | A | ASSIGNED TO LIE | 018 |
01/30/2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 017 |
07/30/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 016 |
07/30/2019 | GNRT | O | NON-FINAL ACTION E-MAILED | 015 |
07/30/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 014 |
07/29/2019 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | 013 |
07/16/2019 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | 012 |
07/01/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 011 |
06/11/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 010 |
06/11/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 009 |
06/11/2019 | ALIE | A | ASSIGNED TO LIE | 008 |
06/05/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
03/01/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
03/01/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
03/01/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
02/28/2019 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
02/25/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
02/05/2019 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Vernicka Shaw |
CORRESPONDENCE ADDRESS | Vernicka Shaw Axogen Corporation 13631 Progress Blvd., Suite 400 Alachua, FL 32615 |
DOMESTIC REPRESENTATIVE | NONE |